Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Melanoma 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Carcinoma, Renal Cell 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Radiotherapy, Intensity-Modulated 7Cisplatin 7Carboplatin 5Surveys and Questionnaires 3Paclitaxel 3Taxes 2Radiation 2Docetaxel 2Cetuximab 2Albumin-Bound Paclitaxel 2utomilumab 1toripalimab 1infigratinib 1fludarabine phosphate 1fludarabine 1durvalumab 1aldesleukin 1Specimen Handling 1Radiotherapy 1Platinum 1Nimorazole 1Mass Screening 1Liquid Biopsy 1Immunoglobulin G 1Hydroxyurea 1Gene Expression Profiling 1Focus Groups 1Fluorouracil 1Drug Therapy 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papillomavirus Infections × utomilumab × Head & Neck × Clear all
NCT03258008 2022-12-16

Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 7 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡